Schedule 13G ownership disclosure
Arcturus Therapeutics Ltd.
Security class unavailable · CUSIP: M1492T105
Event date: 2018-06-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-18-001900
- Form type
- SC 13G
- Filer
- Arcturus Therapeutics Ltd.
- CIK
- CIK 1566049
- Filed
- Jun 11, 2018
- Reporting period
- Jun 11, 2018
- Description
- Schedule 13G beneficial ownership